The University of Chicago Genetic Services is a leader in providing clinical genetic testing and we are pleased to introduce our Ataxia Exome Panel to our menu of exome sequencing tests.

Ataxias are a heterogeneous group of neurological disorders affecting individuals of all age groups and are characterized by the incoordination of voluntary movements.  Features can include cerebellar dysfunction involving disturbance of stance, gait, eye movements, muscle tone, skilled movements and speech.

In a competitive market, we know that our clients have  many options for molecular genetic testing.  We have recently reduced the cost of testing for many of our Sanger Sequencing tests.  We are pleased to offer our clients the same high quality service at a lower cost.  Please visit our website www.dnatesting.uchicago.edu for comprehensive information on all our tests including prices, CPT codes, turnaround times and specimen requirements. 

This poster (#2776T) will be presented at the ASHG Annual Meeting by Agata Minor, our molecular fellow, Thursday October 24: 11:30am-12:30pm. Stop by and learn more.

The University of Chicago Genetic Services Introduces over Fifty New Tests including new and expanded multi-gene sequencing panels.

Coffin-Siris syndrome

• New next generation sequencing and array-CGH deletion/duplication panels for Coffin-Siris syndrome (6 genes) — now available

Congenital Contractures

In addition to our existing testing for Early Infantile Epileptic Encephalopathy , The University of Chicago Genetic Services Introduces a New Next Generation Sequencing Panels for Infantile and Childhood Epilepsy.

The University of Chicago Genetic Services Introduces New Testing for Kabuki syndrome